FDA Dataset Helps Firms Scrutinize Third-Party Chemistry Labs

Medical devices that contact the human body undergo biocompatibility safety assessments prior to market release, including tests for physiochemical properties.  The Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) recently released a dataset to assist medical device firms in this process.  The information addresses capabilities of third-party analytical chemistry labs….
By: Knobbe Martens
Previous Story

Best Practices for Apps & Websites to Avoid Claims Under the California Invasion of Privacy Act (CIPA)

Next Story

Navigating California’s Surge in CIPA Cases: How to Safeguard Websites Using Third-Party Tech